Antibody–Drug Conjugates as an Emerging Therapy in Oncodermatology

SIMPLE SUMMARY: Currently, the therapeutic arsenal to fight cancers is extensive. Among these, antibody–drug conjugates (ADCs) consist in an antibody linked to a cytotoxic agent, allowing a specific delivery to tumor cells. ADCs are an emerging class of therapeutics, with twelve FDA- and EMA-approve...

Descripción completa

Detalles Bibliográficos
Autores principales: Esnault, Clara, Schrama, David, Houben, Roland, Guyétant, Serge, Desgranges, Audrey, Martin, Camille, Berthon, Patricia, Viaud-Massuard, Marie-Claude, Touzé, Antoine, Kervarrec, Thibault, Samimi, Mahtab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833781/
https://www.ncbi.nlm.nih.gov/pubmed/35159045
http://dx.doi.org/10.3390/cancers14030778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833781/
https://www.ncbi.nlm.nih.gov/pubmed/35159045
http://dx.doi.org/10.3390/cancers14030778

Ejemplares similares